Skip to main content

Table 1 Patient demographics and disease characteristics

From: Decline in health-related quality of life and foot and ankle patient reported outcomes measures in patients with haemophilia and ankle haemarthropathy

Severity and treatment

Mean (SD)

Haemophilia A

Haemophilia B

Severe

Number

184/ 75.7%

30/ 12.3%

Age

42.4 (13.1)

47.3 (11.5)

Prophylaxis/ on-demand treatment

164 (67.5%)/ 20 (8.2%)

27 (11.1%) / 3 (1.2%)

Current inhibitor

16/ 6.6%

1/ 0.4%

Height (cm)

176.9 (7.4)

177.6 (7.3)

Weight (Kg)

84.1 (18.3)

89.4 (19.9)

BMI (Kg/m2)

26.7 (5.3)

27.8 (7.1)

Moderate

Number

25/ 10.3%

4/ 1.7%

Age

48.9 (15.9)

46.6 (18.1)

Prophylaxis/ on-demand

11 (4.5%)/ 14 (5.8%)

3 (1.2%)/ 1 (0.4%)

Current inhibitor

1/ 0.4%

0

Height (cm)

177.2 (7.9)

180.6 (9.6)

Weight (Kg)

85.0 (16.2)

98.4 (18.9)

BMI (Kg/m2)

26.8 (4.4)

30.1 (4.5)

  1. BMI Body Mass Index, SD Standard deviation, IQR Interquartile range (25 and 75 percentile), † Only three participants reported treatment dose therefore no IQR reported, ‡ Data not reported